Pulse Biosciences today announced feasibility study data supporting its Nanosecond PFA 360° cardiac catheter system.
MIAMI--(BUSINESS WIRE)--Pulse Biosciences ... study is intended to assess the initial safety and efficacy of the Nanosecond PFA 360° Cardiac Catheter System for the treatment of AF (NCT06696170).